Provided by Tiger Fintech (Singapore) Pte. Ltd.

Legend Biotech

31.48
+1.123.69%
Post-market: 30.66-0.8200-2.60%19:21 EDT
Volume:2.24M
Turnover:70.28M
Market Cap:5.80B
PE:-26.45
High:32.18
Open:31.62
Low:30.70
Close:30.36
Loading ...

Legend Biotech Is Maintained at Buy by Truist Securities

Dow Jones
·
15 May

Legend Biotech Price Target Maintained With a $55.00/Share by Cantor Fitzgerald

Dow Jones
·
14 May

BUZZ-Legend Biotech slips after brokerages cut PT

Reuters
·
14 May

Stock Track | Legend Biotech Plummets 5% as Analysts Cut Price Targets Following Q1 Results

Stock Track
·
14 May

Legend Biotech Secures New Headquarters in Bridgewater

TIPRANKS
·
14 May

Legend Biotech price target lowered to $71 from $88 at Truist

TIPRANKS
·
14 May

Legend Biotech USA Inc. Signs Lease for New Global Headquarters in Bridgewater, New Jersey

Reuters
·
14 May

Truist Securities Adjusts Legend Biotech Price Target to $71 From $88, Maintains Buy Rating

MT Newswires Live
·
14 May

Legend Biotech Corp : Truist Securities Cuts Target Price to $71 From $88

THOMSON REUTERS
·
14 May

Legend Biotech’s Strong Market Position and Growth Potential Drive Buy Rating

TIPRANKS
·
14 May

Legend Biotech Corp : RBC Cuts Target Price to $78 From $84

THOMSON REUTERS
·
14 May

William Blair Reaffirms Their Hold Rating on Legend Biotech (LEGN)

TIPRANKS
·
14 May

Stock Track | Legend Biotech Plummets 5.19% Despite Narrower Q1 Loss and Strong CARVYKTI® Sales

Stock Track
·
13 May

Stock Track | Legend Biotech Plummets 5.19% as Q1 Net Loss Widens to $100.9 Million Despite Strong CARVYKTI Sales

Stock Track
·
13 May

Legend Biotech Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

Sector Update: Health Care Stocks Mixed Premarket Tuesday

MT Newswires Live
·
13 May

BRIEF-Legend Biotech Corporation Q1 Net Income USD -100.916 Million

Reuters
·
13 May

GenScript Announces Legend Biotech’s Q1 2025 Financial Results

TIPRANKS
·
13 May

Legend Biotech Q1 Loss Narrows, Revenue Rises

MT Newswires Live
·
13 May

Legend Biotech Q1 Adj. EPS $(0.07) Beats $(0.23) Estimate, Sales $195.05M Beat $193.62M Estimate

Benzinga
·
13 May